Log in
Log in
E-mail
Password

Show password
Remember
Forgot password ?
Become a member for free
Sign up
Become a member for free
Sign up
New member
Sign up for FREE
New customer
Discover our services
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Gilead Sciences, Inc.
  6. News
  7. Official Publications
    GILD   US3755581036

GILEAD SCIENCES, INC.

(GILD)
  Report
Delayed Nasdaq  -  05/13 04:00:00 pm EDT
62.37 USD   -0.18%
05/13UBS Adjusts Gilead Sciences Price Target to $64 From $65, Maintains Neutral Rating
MT
05/11New class of cancer drugs down, not out, after Roche trial setback - analysts
RE
05/11Blow to Roche's cancer immunotherapy prospects as 2nd trial fails
RE
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Official Publications
04/28/22SEC Filing 10Q-1 
04/28/22Press Release 
04/28/221st quarter results 
04/28/22SEC Filing 8K 
03/07/22SEC Filing 8K 
03/03/22Report 
02/23/22SEC Filing 10K 
02/17/22Report 
02/17/22Report 
02/11/22Report 
02/11/22Report 
02/10/22Report 
02/01/22Press Release 
02/01/22Annual results 
02/01/22Dividends 
02/01/22SEC Filing 8K 
01/26/22Report 
01/05/22SEC Filing 8K 
12/30/21Report 
12/08/21Report 
11/10/21Report 
11/03/21SEC Filing 10Q-3 
10/28/21Press Release 
10/28/213rd quarter results 
10/28/21SEC Filing 8K 
10/22/21Report 
09/29/21Report 
08/17/21Report 
08/15/21Report 
08/10/21Report 
08/05/21SEC Filing 10Q-2 
07/29/21Press Release 
07/29/21Half-year results 
07/29/21SEC Filing 8K 
07/24/21Report 
06/29/21Report 
06/15/21Report 
06/10/21Report 
05/12/21SEC Filing 8K 
05/12/21Report 
05/12/21SEC Filing 8K 
05/12/21Report 
05/06/21Report 
05/06/21Report 
05/06/21SEC Filing 10Q-1 
05/04/21Report 
05/03/21Report 
04/29/21Dividends 
04/29/21SEC Filing 8K 
04/29/21Press Release 
04/29/211st quarter results 
03/30/21Report 
03/01/21Report 
02/15/21Report 
02/10/21Report 
02/06/21Report 
02/04/21Press Release 
02/04/21Annual results 
02/04/21Dividends 
02/04/21SEC Filing 8K 
02/01/21Report 
01/28/21Report 
01/26/21Report 
01/22/21Report 
01/19/21Nomination 
01/11/21SEC Filing 8K 
12/31/20SEC Filing 10K 
12/31/20SEC Filing 8K 
12/30/20Report 
12/29/20Report 
12/10/20Acquisition 
12/08/20Report 
12/07/20SEC Filing 8K 
11/10/20Report 
11/03/20Report 
1  2Next
Analysis
GSK to buy Sierra Oncology amid pressure to boost drug pipeline
Official Publications
04/28SEC Filing 10Q-1 
04/28Press Release 
04/281st quarter results 
04/28SEC Filing 8K 
03/07SEC Filing 8K 
03/03Report 
Upcoming event on GILEAD SCIENCES, INC.
06/02/22Bernstein Strategic Decisions Conference
Upcoming sector events
07/27/22VERTEX PHARMACEUTICALS INCORPORATED : Interim 2022 Earnings Release (Projected)
08/04/22REGENERON PHARMACEUTICALS, INC. : Interim 2022 Earnings Release (Projected)
08/08/22BIONTECH SE : Interim 2022 Earnings Release
08/23/22WUXI APPTEC CO., LTD. : Interim 2022 Earnings Release (Projected)
Sector
Healthcare
Pharmaceuticals & Medical Research
 Biotechnology & Medical Research
  Biotechnology & Medical Research
   Bio Therapeutic Drugs